Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124176142 | 12417614 | 2 | F | 2015 | 20160624 | 20160530 | 20160701 | EXP | PHHY2016ES070253 | NOVARTIS | 56.00 | YR | F | Y | 0.00000 | 20160701 | MD | ES | ES |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124176142 | 12417614 | 1 | PS | TASIGNA | NILOTINIB | 1 | Unknown | 400 MG, BID | Y | 22068 | 400 | MG | CAPSULE | BID | |||||
124176142 | 12417614 | 2 | SS | TASIGNA | NILOTINIB | 1 | Unknown | 300 MG, BID | Y | 22068 | 300 | MG | CAPSULE | BID | |||||
124176142 | 12417614 | 3 | SS | TASIGNA | NILOTINIB | 1 | Unknown | 150 MG, BID | Y | 22068 | 150 | MG | CAPSULE | BID | |||||
124176142 | 12417614 | 4 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | U | 0 | ||||||||||
124176142 | 12417614 | 5 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | U | 0 | ||||||||||
124176142 | 12417614 | 6 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | U | 0 | ||||||||||
124176142 | 12417614 | 7 | C | SINTROM | ACENOCOUMAROL | 1 | Unknown | U | 0 | ||||||||||
124176142 | 12417614 | 8 | C | INSULIN | INSULIN NOS | 1 | Unknown | U | 0 | ||||||||||
124176142 | 12417614 | 9 | C | VALSARTAN. | VALSARTAN | 1 | Unknown | U | 0 | ||||||||||
124176142 | 12417614 | 10 | C | SEGURIL | FUROSEMIDE | 1 | Unknown | U | 0 | ||||||||||
124176142 | 12417614 | 11 | C | EMCONCOR | BISOPROLOL FUMARATE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124176142 | 12417614 | 1 | Chronic myeloid leukaemia |
124176142 | 12417614 | 4 | Product used for unknown indication |
124176142 | 12417614 | 5 | Product used for unknown indication |
124176142 | 12417614 | 6 | Product used for unknown indication |
124176142 | 12417614 | 7 | Product used for unknown indication |
124176142 | 12417614 | 8 | Product used for unknown indication |
124176142 | 12417614 | 9 | Product used for unknown indication |
124176142 | 12417614 | 10 | Product used for unknown indication |
124176142 | 12417614 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124176142 | 12417614 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124176142 | 12417614 | Arthralgia | |
124176142 | 12417614 | Asthenia | |
124176142 | 12417614 | Cardiac failure | |
124176142 | 12417614 | Pleural effusion | |
124176142 | 12417614 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124176142 | 12417614 | 1 | 200905 | 201210 | 0 | |
124176142 | 12417614 | 2 | 201210 | 201601 | 0 | |
124176142 | 12417614 | 3 | 201601 | 0 |